{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:31:42Z","timestamp":1789173102515,"version":"build-2803163510"},"reference-count":20,"publisher":"Bioscientifica","content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,11,17]]},"abstract":"Summary<\/jats:title>\n Insulin antibodies (IA) associated with exogenous insulin administration seldom caused hypoglycemia and had different characteristics from insulin autoantibodies (IAA) found in insulin autoimmune syndrome (IAS), which was first described by Dr Hirata in 1970. The characteristic of IAS is the presence of insulin-binding autoantibodies and related fasting or late postprandial hypoglycemia. Here, we report a patient with type 1 diabetes mellitus under insulin glargine and insulin aspart treatment who developed recurrent spontaneous post-absorptive hyperinsulinemic hypoglycemia with the cause probably being insulin antibodies induced by exogenous injected insulin. Examinations of serial sera disclosed a high titre of insulin antibodies (33%, normal <5%), high insulin concentration (111.9\u2009IU\/mL) and undetectable C-peptide when hypoglycemia occurred. An oral glucose tolerance test revealed persistent high serum levels of total insulin and undetectable C-peptide. Image studies of the pancreas were unremarkable, which excluded the diagnosis of insulinoma. The patient does not take any of the medications containing sulfhydryl compounds, which had been reported to cause IAS. After administering oral prednisolone for 3 weeks, hypoglycemic episodes markedly improved, and he was discharged smoothly.<\/jats:p>\n \n Learning points:<\/jats:title>\n \n \n Insulin autoimmune syndrome (IAS) or IAS-like situation should be one of the differential diagnosis in patients with hyperinsulinemic hypoglycemia.<\/jats:p>\n <\/jats:list-item>\n \n Although less reported, insulin antibodies (IA) caused by exogenous insulin analog should be considered as the cause of hypoglycemia.<\/jats:p>\n <\/jats:list-item>\n \n Patients with suspected insulin autoimmune syndrome (IAS) should be screened for drugs related to autoimmunity to endogenous insulin.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:sec>","DOI":"10.1530\/edm-16-0079","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T05:33:33Z","timestamp":1479360813000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":10,"title":["Hyperinsulinemic hypoglycemia associated with insulin antibodies caused by exogenous insulin analog"],"prefix":"10.1530","volume":"2016","author":[{"given":"Chih-Ting","family":"Su","sequence":"first","affiliation":[{"name":"1Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Lin","sequence":"additional","affiliation":[{"name":"1Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan"},{"name":"2Department of Medicine, Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"key20161122122524166_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/eje.0.1450311","article-title":"Hypoglycaemia due to insulin autoimmune syndrome: report of two cases with characterisation of HLA alleles and insulin autoantibodies.","volume":"145","author":"Cavaco","year":"2001","journal-title":"European Journal of Endocrinology"},{"key":"key20161122122524166_bib2","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2337\/diab.44.10.1227","article-title":"Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome (Hirata\u2019s disease) and monoclonal insulin autoimmune syndrome","volume":"44","author":"Uchigata","year":"1995","journal-title":"Diabetes"},{"key":"key20161122122524166_bib3","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.diabres.2009.02.007","article-title":"Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies","volume":"84","author":"Ishizuka","year":"2009","journal-title":"Diabetes Research and Clinical Practice"},{"key":"key20161122122524166_bib4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.diabres.2005.10.018","article-title":"A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy","volume":"72","author":"Matsuyoshi","year":"2006","journal-title":"Diabetes Research and Clinical Practice"},{"key":"key20161122122524166_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/00365519009089170","article-title":"Prevalence of antiinsulin antibodies and its relation to severe hypoglycaemia in insulin-treated diabetic patients","volume":"50","author":"Wredling","year":"1990","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"key20161122122524166_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/diacare.12.9.641","article-title":"Clinical significance of insulin antibodies in insulin-treated diabetic patients","volume":"12","author":"Van Haeften","year":"1989","journal-title":"Diabetes Care"},{"key":"key20161122122524166_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2014.03.008","article-title":"Development of insulin antibodies and changes in titers over a long-term period in patients with type 2 diabetes","volume":"433","author":"Hattori","year":"2014","journal-title":"Clinica Chimica Acta"},{"key":"key20161122122524166_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/diab.27.6.653","article-title":"Equilibrium binding assay and kinetic characterization of insulin antibodies","volume":"27","author":"Goldman","year":"1978","journal-title":"Diabetes"},{"key":"key20161122122524166_bib9","first-page":"245","article-title":"Insulin autoimmune syndrome (IAS, Hirata disease)","volume":"150","author":"Uchigata","year":"1999","journal-title":"Annales de M\u00e9decine Interne"},{"key":"key20161122122524166_bib10","doi-asserted-by":"crossref","first-page":"130086","DOI":"10.1530\/EDM-13-0086","article-title":"Analytical and clinical challenges in a patient with concurrent type 1 diabetes, subcutaneous insulin resistance and insulin autoimmune syndrome","volume":"2014","author":"Jassam","year":"2014","journal-title":"Endocrinology, Diabetes and Metabolism Case Reports"},{"key":"key20161122122524166_bib11","doi-asserted-by":"crossref","first-page":"746271","DOI":"10.1155\/2015\/746271","article-title":"Immunological hypoglycemia associated with insulin antibodies induced by exogenous insulin in 11 Chinese patients with diabetes","volume":"2015","author":"Quan","year":"2015","journal-title":"Journal of Diabetes Research"},{"key":"key20161122122524166_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3803\/EnM.2013.28.1.55","article-title":"Two cases of Methimazole-induced insulin autoimmune syndrome in Graves\u2019 disease","volume":"28","author":"Roh","year":"2013","journal-title":"Endocrinology and Metabolism"},{"key":"key20161122122524166_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00000441-200505000-00007","article-title":"Hypoglycemia and hyperglycemia due to insulin antibodies against therapeutic human insulin: treatment with double filtration plasmapheresis and prednisolone","volume":"329","author":"Koyama","year":"2005","journal-title":"American Journal of the Medical Sciences"},{"key":"key20161122122524166_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/jcem-62-1-64","article-title":"Characterization of circulating insulin in insulin autoimmune syndrome","volume":"62","author":"Seino","year":"1986","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"key20161122122524166_bib15","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.4103\/0366-6999.163376","article-title":"Insulin autoimmune syndrome: 73 cases of clinical analysis","volume":"128","author":"Wang","year":"2015","journal-title":"Chinese Medical Journal"},{"key":"key20161122122524166_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1726-4901(09)70140-6","article-title":"Severe hypoglycemic coma due to insulin autoimmune syndrome","volume":"68","author":"Ma","year":"2005","journal-title":"Journal of the Chinese Medical Association"},{"key":"key20161122122524166_bib17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0002-9343(85)90294-3","article-title":"Insulin antibodies in patients receiving penicillamine","volume":"78","author":"Benson","year":"1985","journal-title":"American Journal of Medicine"},{"key":"key20161122122524166_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0002-9343(92)90787-C","article-title":"Reactive hypoglycemic coma due to insulin autoimmune syndrome: case report and literature review.","volume":"92","author":"Burch","year":"1992","journal-title":"American Journal of Medicine"},{"key":"key20161122122524166_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1210\/er.2007-0002","article-title":"Immunological responses to exogenous insulin","volume":"28","author":"Fineberg","year":"2007","journal-title":"Endocrine Reviews"},{"key":"key20161122122524166_bib20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/diacare.12.9.641","article-title":"Clinical significance of insulin antibodies in insulin-treated diabetic patients","volume":"12","author":"Van Haeften","year":"1989","journal-title":"Diabetes Care"}],"container-title":["Endocrinology, Diabetes & Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2016\/1\/EDM16-0079.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2016\/1\/EDM16-0079.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:46:22Z","timestamp":1784555182000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1530\/edm-16-0079","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,17]]}}}